Autopsy report · NCT00910273
Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 3 months before it stopped.
- 34 participants enrolled.
- Results were posted on the registry 4 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Ankylosing Spondylitis
- Interventions
- etanercept
- Participants
- 34
- Sites
- 4
- Countries
- Italy
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.